Find your next paid study

Vensica Therapeutics Ltd.NCT07553065

~$75 – $2,800

Actual pay is set by the research site.

Tobacco Use CessationAddiction

Evaluation Tobacco Prevention Toolkit Healthy Futures: Alternative-to-Suspension Vaping Intervention

The Healthy Futures: Alternative-to-Suspension Curriculum is a free, online curriculum developed to educate students and provide them with resources to quit to…

Stanford UniversityNCT06483412

~$10 – $750

Actual pay is set by the research site.

Advanced MalignanciesAdvanced Cancer

AN OPEN-LABEL PHASE 1 STUDY TO EVALUATE PF-07994525 IN PARTICIPANTS WITH ADVANCED MALIGNANCIES

This is an open-label, dose escalation and dose expansion study evaluating the safety, tolerability, Pharmacokinetic (PK), Pharmacodynamic (PD), and antitumor …

~$150 – $4,500

Actual pay is set by the research site.

PfizerNCT07426757

Breast CancerCervical CancerBladder Cancer+4 more

An Adaptive Design for Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

The purpose of this study is to assess the best time to deliver a message to increase physical activity and how often participants will experience a pain episo…

Medical College of WisconsinNCT07227077

~$10 – $750

Actual pay is set by the research site.

Solid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more

A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated Tmod™ CAR T, in Heterozygous HLA-A02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express EGFR and Have Lost HLA-A02 Expression

The goal of this study is to test A2B395, an allogeneic logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorectal cancer (CRC), n…

Advanced Malignant Solid NeoplasmAdvanced Biliary Tract CarcinomaAdvanced Esophageal Carcinoma+7 more

~$150 – $4,200

Actual pay is set by the research site.

A2 Biotherapeutics Inc.

Phase 2

ACTO: A Phase II, Randomized, Placebo-Controlled Study Evaluating Olanzapine in the Management of Cancer Cachexia

This phase II trial tests how well olanzapine works in managing cancer cachexia in patients experiencing esophagogastric, hepatopancreaticobiliary, colorectal,…

OHSU Knight Cancer InstituteNCT05705492

~$75 – $3,000

Actual pay is set by the research site.

Prospective Randomized Controlled Trial Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking …

Adenoma Colon Polyp

~$10 – $1,125

Actual pay is set by the research site.

AdventHealthNCT06476145

Metastatic Colorectal AdenocarcinomaRecurrent Colorectal AdenocarcinomaRefractory Colorectal Adenocarcinoma+1 more

A Phase 1 Study of ZEN003694 (ZEN-3694) in Combination With Cetuximab and Encorafenib in Patients With Refractory BRAF V600E Metastatic Colorectal Cancer

This phase I trial tests the safety, best dose, and effectiveness of ZEN003694 in combination with cetuximab and encorafenib in treating patients with colorect…

National Cancer Institute (NCI)NCT06102902

~$150 – $2,700

Actual pay is set by the research site.

Phase 2

Phase 2 Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer

To determine the effects of exercise therapy on molecular, radiologic, and pathologic nimbosus hallmarks versus usual care control in men on Active Surveillanc…

Prostate CancerProstate AdenocarcinomaLocalized Prostate Carcinoma

City of Hope Medical CenterNCT05751434

~$75 – $2,000

Actual pay is set by the research site.

ADHDSleep DisturbanceBrain Fog

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications

This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative s…

Outliers, Inc.NCT07380412

~$10 – $1,050

Actual pay is set by the research site.

Advanced CancerMetastatic Solid Tumor

A Phase Ia/Ib, Open-Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC3195 in Patients With Locally Advanced or Metastatic Solid Tumors

This is a phase Ia/Ib, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of B…

Biocity Biopharmaceutics Co., Ltd.NCT06548672

~$150 – $4,200

Actual pay is set by the research site.

PAD - Peripheral Arterial DiseaseVascular DiseasesWounds

Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies

The ability to have a visual aid to depict areas of vascular disease that are affecting the patient's health can help in patient comprehension of the problem. …